Biomea Fusion BMEA
NASDAQ BMEA
$0.75 +0.01 (+1.92%)
As of: Oct 21, 2026 · 10:32 AM EDT

Biomea Fusion (BMEA) Cash & Equivalents (2020 - 2026)

Updated

Biomea Fusion (BMEA) posted Cash & Equivalents of $34.82 million for Q2 2026, down 38.1% from $56.22 million a year earlier and down 22.1% from the prior quarter.

Analysis

Biomea Fusion (BMEA) Cash & Equivalents (2020 - 2026) Analysis & Trends

At the end of FY2025, Biomea Fusion's Cash & Equivalents came in at $55.81 million, down 4.8% from FY2024.

  • Annual Cash & Equivalents shows a five-year compound annual growth rate of -2.0% (FY2020 to FY2025).
  • In prior years, Biomea Fusion's Cash & Equivalents was $58.65 million in FY2024 (-66.9%), $177.24 million in FY2023 (+57.9%), $112.25 million in FY2022 (-23.2%) and $146.09 million in FY2021 (+136.8%).
  • The Q2 2026 figure stands as the lowest quarterly Cash & Equivalents since Q1 2021.
  • On a year-over-year basis, Cash & Equivalents increased in 1 of the last eight quarters, with an average decline of 39.2%.
  • The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2022, with growth of 719.4%; the weakest was Q1 2025, with a decline of 75.3%.
  • According to Business Quant data, Cash & Equivalents for the three prior quarters was $44.69 million (Q1 2026), $55.81 million (Q4 2025) and $47.01 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.80 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 614.95 Bn 533.47 Bn 17.26 Bn 20.42 Bn
3 AbbVie 505.05 Bn 478.16 Bn 12.70 Bn 6.57 Bn
4 Merck 368.08 Bn 322.46 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 298.32 Bn 262.31 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 261.58 Bn 235.26 Bn 12.86 Bn 4.90 Bn
7 Amgen 236.05 Bn 191.45 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 190.61 Bn 164.80 Bn 6.22 Bn 3.18 Bn
9 Pfizer 169.86 Bn 116.50 Bn 10.94 Bn 976.00 Mn
10 Biomea Fusion 53.54 Mn -128.80 Mn - 34.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.82 Mn
Mar 31, 2026 44.69 Mn
Dec 31, 2025 55.81 Mn
Sep 30, 2025 47.01 Mn
Jun 30, 2025 56.22 Mn
Mar 31, 2025 35.86 Mn
Dec 31, 2024 58.65 Mn
Sep 30, 2024 88.32 Mn
Jun 30, 2024 113.66 Mn
Mar 31, 2024 145.29 Mn
Dec 31, 2023 177.24 Mn
Sep 30, 2023 199.46 Mn
Jun 30, 2023 223.26 Mn
Mar 31, 2023 86.65 Mn
Dec 31, 2022 112.25 Mn
Sep 30, 2022 132.66 Mn
Jun 30, 2022 148.83 Mn
Mar 31, 2022 156.57 Mn
Dec 31, 2021 146.09 Mn
Sep 30, 2021 157.19 Mn
API Access

Biomea Fusion Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BMEA&period=max&api_key=YOUR_API_KEY